As fundraising becomes tougher in the volatile market, with many LPs at or above their allocation caps, more GPs may use tender offers as a way to reach their fundraising targets.
3 min read · 18 August 2022
Rabo Investments also invested in the deal centred on vitamin, mineral and supplement soft gel manufacturer Captek Softgel International.
2 min read · 17 August 2022
The level of dry powder for secondaries sits at $94bn, up year-on-year and a slight decrease from the $105bn available for deployment at the end of 2021, according to Evercore’s H1 Secondary Market report.
4 min read · 16 August 2022
The VC and growth firm has established 10 sustainability goals, inspired by the UN SDGs, and in December published its first annual report on progress against these.
1 min read · 15 August 2022
The New York-headquartered firm surpassed its $2bn target for Pomona Capital X, which is 44% larger than its predecessor.
2 min read · 12 August 2022
Experts from Greenhill, NewQuest and LGT Capital Partners discuss what’s driving secondaries dealflow in Asia-Pacific this year.
5 min read · 11 August 2022
With the launch of S3, Apollo becomes ‘much more of a one-stop relationship’ for GPs, co-president Scott Kleinman tells Secondaries Investor.
5 min read · 11 August 2022
Any attempts to streamline the GP-led process should provide guardrails, write Maurice Gindi, Kenneth Blazejewski and Sophie Smith from law firm Cleary Gottlieb.
4 min read · 10 August 2022
Capital raised for secondaries fell 30% to $31.2bn in the first half of 2022, according to data compiled by Secondaries Investor.
2 min read · 09 August 2022
Robert Emerson joins from Kirkland & Ellis, where his clients included Whitehorse Liquidity Partners, Vista Equity Partners and Two Sigma.
2 min read · 08 August 2022
